Cargando…
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma
Renal Cell Carcinomas (RCCs) are heterogeneous tumors with late acquisition of TP53 abnormalities during their evolution. They harbor TP53 abnormalities in their metastases. We aimed to study TP53 gene alterations in tissue samples from primary and metastatic RCCs in 36 patients followed up over a m...
Autores principales: | Bousquet, Guilhem, Bouchtaoui, Morad El, Leboeuf, Christophe, Battistella, Maxime, Varna, Mariana, Ferreira, Irmine, Plassa, Louis-François, Hamdan, Diaddin, Bertheau, Philippe, Feugeas, Jean-Paul, Damotte, Diane, Janin, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662490/ https://www.ncbi.nlm.nih.gov/pubmed/26002555 |
Ejemplares similares
-
TP53 Status and Response to Treatment in Breast Cancers
por: Varna, Mariana, et al.
Publicado: (2011) -
Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes
por: Furet, Elise, et al.
Publicado: (2017) -
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
por: Bousquet, Guilhem, et al.
Publicado: (2017) -
Targeting Cancer Stem Cells to Overcome Chemoresistance
por: Nunes, Toni, et al.
Publicado: (2018) -
Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia
por: Hamdan, Diaddin, et al.
Publicado: (2019)